Post by BridgeBio

Today, we raised up to $1 billion preferred equity investment from Sixth Street and HealthCare Royalty to accelerate the global expansion of Attruby, support three near-term U.S. product launches in LGMD2I/R9, ADH1, and achondroplasia, and invest in expansion indications. Learn more: https://bit.ly/4eTii1i